ARRA OS: Recovery Act 2009: Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18)

The summary for the ARRA OS: Recovery Act 2009: Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
ARRA OS: Recovery Act 2009: Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18): Purpose. This ASPE FOA, supported by funds provided to ASPE under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, invites grant applications from organizations that propose to develop and test interventions to improve the translation and adoption of existing comparative effectiveness research (CER) information and incorporate these findings into practice in both the public and private sectors. Doing so effectively would demonstrate a return on the CER investment, and, more importantly, improve the health of patients. Funds will be used to support organizations that 1) develop and implement evidence-informed and innovative CER-based adoption interventions targeting patients and/or providers; 2) develop proposals that test the implementation of CER-based adoption strategies within and across organizations and delivery systems and analyze any behavior change (in patients and/or providers) associated with the intervention. CER-based entails the applicant describing and justifying the existing comparative evidence that is the focus of the adoption intervention. Organizations applying for these funds will need to utilize existing or create new measurement systems to track adoption or adherence rates (thus measuring clinician and patient behavior changes) associated with the adoption of CER and measurement of health outcomes if possible. Applicants should also seek to understand the underlying factors associated with adoption. Mechanism of Support. This FOA will utilize the R18 grant mechanism Funds Available and Anticipated Number of Awards. $300,000 to $3,000,000 per award; 5-10 awards
Federal Grant Title: ARRA OS: Recovery Act 2009: Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Recovery Act
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AE-10-001
Type of Funding: Grant
CFDA Numbers: 93.726
CFDA Descriptions: ARRA Accelerating Adoption of Comparative Effectiveness Research (CER)
Current Application Deadline: Mar 11, 2010
Original Application Deadline: Mar 11, 2010
Posted Date: Jan 11, 2010
Creation Date: Jan 11, 2010
Archive Date: Apr 11, 2010
Total Program Funding: $14,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Private institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following: Integrated health care systems Integrated provider systems Academic Medical Centers Provider consortia Community Health Center Networks Private payers Other non-governmental organizations that administer or directly provide health care services Organizations that serve health care consumers University-based school (e.g. School of Public Policy or Public Health) Private research institutes
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
More Grants from the National Institutes of Health
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com